Study to Assess the Effectiveness and Safety of Lenacapavir for Human Immunodeficiency Virus (HIV) Pre-Exposure Prophylaxis
Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!
Summary
- Eligibility
- for people ages 16 years and up (full criteria)
- Healthy Volunteers
- healthy people welcome
- Location
- at UCLA UCSD
- Dates
- study startestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Gilead Sciences
- Links
- Gilead Clinical Trials Website
- ID
- NCT04925752
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- Expecting 3000 study participants
- Last Updated